Latest Content

Understanding Breast Cancer Biomarkers Drives Patient Treatment Decisions

June 10th 2025, 4:00pm

By Kristie L. Kahl

Article

Dr. Mabel Mardones educates patients on breast cancer subtypes, as well as treatment options for those with ER-positive, HER2-negative disease.

FDA Grants Fast Track Status to PHST001 for Ovarian Cancer Treatment

June 10th 2025, 3:18pm

By Spencer Feldman

Article

The FDA grants fast track designation to PHST001, an antibody targeting CD24, for advanced platinum-resistant and platinum-sensitive ovarian cancer.

Expanding on a New Way to Manage Polycythemia Vera Without Iron Deficiency

June 10th 2025, 1:00pm

By Aaron Gerds, MD, MS

Video

The VERIFY trial explores rusfertide to manage polycythemia vera without causing iron deficiency symptoms, Dr. Aaron Gerds explained.

I Sometimes Forget to Celebrate Survivorship

June 9th 2025, 9:00pm

By Mary Sansone

Article

Five years after my transplant for leukemia, I’m learning to focus on gratitude despite daily struggles, remembering that being alive is the greatest gift.

You Are Not Alone While Building a Support Team During Cancer Care

June 9th 2025, 8:00pm

By Michelle Kirschner

Video

Michelle Kirschner discusses the how patients can foster a strong network of supporters from diagnosis through survivorship.

When Treatment Ends, Support Shouldn’t Stop in Cancer Care

June 9th 2025, 7:00pm

By Ryan Scott

Article

Natalie Schnaitmann discusses the importance of self-advocacy and access to second opinions when symptoms are dismissed among young women with cancer.

The Gift of a Good Cancer Nurse

June 9th 2025, 5:00pm

By Martha Carlson

Article

When it comes to living with cancer, your nurses make a difference.

Zilovertamab Vedotin Plus Chemo Combo Shows Responses in R/R DLBCL

June 9th 2025, 4:01pm

By Silas Inman

Article

The antibody-drug conjugate zilovertamab vedotin plus Rituxan and chemotherapy showed an objective response rate of 56.3% in relapsed/refractory DLBCL.

TERZO Trial Doses First Patient With Copiktra in Rare T-Cell Lymphoma

June 9th 2025, 3:00pm

By Spencer Feldman

Article

The first patient has been dosed in the phase 3 TERZO trial of Copiktra for relapsed or refractory nodal T-follicular helper cell lymphoma.

Protect Your Healing by Lowering Chemical Exposure After Cancer Diagnosis

June 9th 2025, 1:28pm

By Dr. Lorenzo Cohen

Video

It is important to understand why it is vital that patients and survivors of cancer take steps to reduce the body’s burden both before and after treatment.

Detailing the Potential Benefit of Intratumoral Therapies in Lung Cancer

June 8th 2025, 6:00pm

By Ryan Scott

Article

Dr. Jared Weiss walks patients through the therapeutic potential viability of intratumoral therapies among those with lung cancer.

Targeted Chemo Improves Survival in Early-Stage Lung Cancer

June 8th 2025, 2:00pm

By Jordyn Sava

Article

Using a 14-gene test to guide chemotherapy significantly improved disease-free survival in patients with early nonsquamous lung cancer.

Utilizing AI in Prostate Cancer Care and Management

June 7th 2025, 6:00pm

By Alex Biese

Article

How artificial intelligence is being used to augment the work of experts treating patients with prostate cancer.

KITE-363 Shows High Response in B-Cell Lymphoma With Manageable Safety

June 7th 2025, 2:00pm

By Kristi Rosa

Article

The dual-targeting CAR T-cell therapy KITE-363 showed positive response rates and manageable side effects in relapsed or refractory B-cell lymphoma.

Zyprexa Added to Standard Antiemetics Reduces Nausea, Vomiting in Radiation

June 6th 2025, 9:00pm

By Roman Fabbricatore

Article

Adding Zyprexa to ondansetron cut nausea and vomiting safely in abdominal/pelvic radiation with low-emetogenic capecitabine.